Overview
Healthcare data provider's Q1 revenue fell 6% but slightly beat analyst expectations
Adjusted net income rose year-over-year to $8.5 mln
Company posted large net loss due to $197 mln goodwill impairment
Outlook
Company expects Q2 2026 revenue of $55.0 mln to $56.0 mln
Definitive Healthcare sees full-year 2026 revenue of $220.0 mln to $226.0 mln
Company expects full-year 2026 adjusted EBITDA of $55.0 mln to $59.0 mln
Result Drivers
RETENTION IMPROVEMENT - Co said it saw improvements in customer retention rates, per CEO Kevin Coop
CUSTOMER WINS - Co highlighted new customer wins and expansion opportunities across all end-markets
Company press release: ID:nGNXY5g8K
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Slight Beat*
$55.93 mln
$55.40 mln (10 Analysts)
Q1 Net Income
-$192.35 mln
Q1 Gross Profit
$41.65 mln
Q1 Pretax Profit
-$195.79 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy."
Wall Street's median 12-month price target for Definitive Healthcare Corp is $2.75, about 191% above its May 6 closing price of $0.95
The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 9 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)